Skip to content
10-Q

Quarterly Report

Kronos Bio, Inc.

0001741830-25-000024

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 60.97M sh
Shares Diluted Q1 2025 · Mar 31, 2025 60.81M sh
Shares Diluted Q1 2025 · Mar 31, 2024 59.52M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $7K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$12.84M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$23.9M
Short Term Investments Q1 2025 · Mar 31, 2025 $8.16M
Short Term Investments Q1 2025 · Dec 31, 2024 $27.85M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $91.58M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $84.57M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $46.2M
Stockholders Equity Q1 2025 · Mar 31, 2025 $79.81M
Stockholders Equity Q1 2025 · Dec 31, 2024 $87.58M
Stockholders Equity Q1 2025 · Mar 31, 2024 $136.97M
Stockholders Equity Q1 2025 · Dec 31, 2023 $159.08M
Current Liabilities Q1 2025 · Mar 31, 2025 $7.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.28M
Total Liabilities Q1 2025 · Mar 31, 2025 $28.33M
Total Liabilities Q1 2025 · Dec 31, 2024 $36.78M
Current Assets Q1 2025 · Mar 31, 2025 $101.87M
Current Assets Q1 2025 · Dec 31, 2024 $115.23M
Total Assets Q1 2025 · Mar 31, 2025 $108.14M
Total Assets Q1 2025 · Dec 31, 2024 $124.36M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.14
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.50
Eps Basic Q1 2025 · Mar 31, 2025 −$0.14
Eps Basic Q1 2025 · Mar 31, 2024 −$0.50
Sga Expense Q1 2025 · Mar 31, 2025 $6.12M
Sga Expense Q1 2025 · Mar 31, 2024 $7.51M
Rd Expense Q1 2025 · Mar 31, 2025 $2.12M
Rd Expense Q1 2025 · Mar 31, 2024 $14.22M
Net Income Q1 2025 · Mar 31, 2025 −$8.36M
Net Income Q1 2025 · Mar 31, 2024 −$29.96M
Operating Income Q1 2025 · Mar 31, 2025 −$9.44M
Operating Income Q1 2025 · Mar 31, 2024 −$31.99M
Revenue Q1 2025 · Mar 31, 2025 $1.86M
Revenue Q1 2025 · Mar 31, 2024 $2.52M